Monday, December 05, 2011

AstraZeneca to share new drugs with academics - Telegraph

Astra's pact with the Medical Research Council (MRC), the first of its kind, will offer 22 clinical compounds to academics for free.

They will be compounds known to have an active biological function, but where it is unclear whether they are targeting the right disease.

Posted via email from Jack's posterous

No comments: